TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.
Business Model:
Revenue: $0
Employees: 11-50
Address: 200 Niudun Rd, Bld 5, Rm 202
City: Shanghai
State: shanghai municipality
Zip: 201203
Country: CN
TriArm Therapeutics is a cell therapy company formed by Panacea Venture with R&a;D operations in Germany, United States and Greater China region. The company focuses on the research and clinical transformation of CD19 CAR-T product using non-viral gene transfer technology, which greatly reduces the cost and time of cell therapy product preparation, enabling better tumor therapy outcome.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Equity | $60M |
Panacea Venture VI venture HT capital efung capital |
7/2019 | Series A | $0 |
Lombard Odier EFung Capital HT Capital Panacea Venture Virtus Inspire Ventures Lombard Odier EFung Capital HT Capital Panacea Venture Virtus Inspire Ventures |
7/2019 | Series A | 5 | $20M |
EFung Capital HT Capital Lombard Odier Panacea Venture Virtus Inspire Ventures EFung Capital HT Capital Lombard Odier Panacea Venture Virtus Inspire Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|